Abstract
BackgroundTNF alpha blockers (TNFb) are effective in spondyloarthritis (SpA); primary inefficacy (defined by lack of treatment response in the first three months of treatment) is unfrequent and has been little...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
